RA Capital Management, L.P. 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-12 5:00 pm Sale |
2023-06-08 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
RA Capital Management, L.P. | 0 0.000% |
-5,944,252 (Position Closed) |
Filing |
| 2023-04-18 4:30 pm Purchase |
2009-02-28 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
RA Capital Management, L.P. | 5,944,252 17.900% |
30,000 (+0.51%) |
Filing |
| 2021-03-02 4:32 pm Purchase |
2009-02-28 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
RA Capital Management, L.P. | 5,914,252 18.800% |
1,232,394 (+26.32%) |
Filing |